[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

TR201105367A2 - Akış özellikleri geliştirilmiş bir kuru toz formülasyonu. - Google Patents

Akış özellikleri geliştirilmiş bir kuru toz formülasyonu.

Info

Publication number
TR201105367A2
TR201105367A2 TR2011/05367A TR201105367A TR201105367A2 TR 201105367 A2 TR201105367 A2 TR 201105367A2 TR 2011/05367 A TR2011/05367 A TR 2011/05367A TR 201105367 A TR201105367 A TR 201105367A TR 201105367 A2 TR201105367 A2 TR 201105367A2
Authority
TR
Turkey
Prior art keywords
dry powder
powder formulation
flow properties
improved flow
present
Prior art date
Application number
TR2011/05367A
Other languages
English (en)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2011/05367A priority Critical patent/TR201105367A2/tr
Priority to TR2012/05852A priority patent/TR201205852A2/tr
Priority to PCT/TR2012/000091 priority patent/WO2012166070A1/en
Priority to PCT/TR2012/000096 priority patent/WO2013009271A1/en
Publication of TR201105367A2 publication Critical patent/TR201105367A2/tr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/17Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Mevcut buluş; astım ve KOAH gibi solunum yolları hastalıklarında kullanılmak üzere geliştirilmiş yeni bir kuru toz formülasyon ile ilgilidir.
TR2011/05367A 2011-06-02 2011-06-02 Akış özellikleri geliştirilmiş bir kuru toz formülasyonu. TR201105367A2 (tr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
TR2011/05367A TR201105367A2 (tr) 2011-06-02 2011-06-02 Akış özellikleri geliştirilmiş bir kuru toz formülasyonu.
TR2012/05852A TR201205852A2 (tr) 2011-06-02 2012-05-21 Geliştirilmiş yeni kuru toz formülasyonu.
PCT/TR2012/000091 WO2012166070A1 (en) 2011-06-02 2012-05-28 Dry powder formulation with improved flow characteristics
PCT/TR2012/000096 WO2013009271A1 (en) 2011-06-02 2012-05-31 New improved dry powder formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2011/05367A TR201105367A2 (tr) 2011-06-02 2011-06-02 Akış özellikleri geliştirilmiş bir kuru toz formülasyonu.

Publications (1)

Publication Number Publication Date
TR201105367A2 true TR201105367A2 (tr) 2012-12-21

Family

ID=46456987

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2011/05367A TR201105367A2 (tr) 2011-06-02 2011-06-02 Akış özellikleri geliştirilmiş bir kuru toz formülasyonu.

Country Status (2)

Country Link
TR (1) TR201105367A2 (tr)
WO (1) WO2012166070A1 (tr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2705838A1 (en) * 2012-09-06 2014-03-12 Xspray Microparticles Ab Tiotropium preparations
EP3823602A4 (en) * 2018-07-20 2022-04-27 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi INHALATION COMPOSITIONS COMPRISING ANTIBACTERIAL AGENTS
IT201900002857A1 (it) * 2019-02-27 2020-08-27 Ntc S R L Procedimento di riempimento di contenitori con una polvere

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20011227A1 (es) * 2000-04-17 2002-01-07 Chiesi Farma Spa Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
GB0219513D0 (en) * 2002-08-21 2002-10-02 Norton Healthcare Ltd Inhalation compositions including coarse carrier
US20040152720A1 (en) * 2002-12-20 2004-08-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Powdered medicaments containing a tiotropium salt and salmeterol xinafoate
EP2221048A1 (en) * 2009-02-18 2010-08-25 Siegfried Generics International AG Pharmaceutical composition for inhalation
EP2563364A1 (en) * 2010-04-26 2013-03-06 Mahmut Bilgic Combination of carmoterol and fluticasone for use in the treatment respiratory diseases
WO2011160920A1 (en) * 2010-06-22 2011-12-29 Chiesi Farmaceutici S.P.A. Dry powder formulation comprising an antimuscarinic drug

Also Published As

Publication number Publication date
WO2012166070A1 (en) 2012-12-06

Similar Documents

Publication Publication Date Title
PL2892808T3 (pl) Kruszywa stabilizowane oraz inne materiały i konstrukcje przeznaczone do pochłaniania energii, lecz nie ograniczające się do tego
FR3000095B1 (fr) Composition comprenant du 2,3,3,3-tetrafluoropropene et du 1,2-difluoroethylene
CO6831975A2 (es) Inmunoconjugados, composiciones para prepararlos, métodos para prepararlos y uso
CL2015000826A1 (es) Composición de material de revestimientos no acuosa que contiene flúor, métodos de revestimiento y el uso de la composición de material de revestimiento
TR201909788T4 (tr) C4-monometil triterpenoid türevleri ve bunların kullanım yöntemleri.
TWD160007S (zh) 車輛引擎蓋(一)
CL2014002037A1 (es) Material mineral en polvo con elevada capacidad de dispersión, y uso de dicho material mineral en polvo
CO6950497A2 (es) Compuestos de 1,2,5-oxadiazol sustituidos y su uso como herbicidas
JP2015513329A5 (ja) 手指衛生順守の決定方法
TR201903918T4 (tr) Bir dağıtım ajanı içeren bileşimler ve bunların hazırlanması.
BR112014017481A2 (pt) formulação em pó seco para uso em um inalador de pó seco, inalador de pó seco e uso de uma formulação
AR092882A1 (es) 1,2,4-triazin-3,5-dion-6-carboxamidas y su uso como herbicidas
TR201109439A2 (tr) Pompa içeren inhalasyon cihazı.
BR112014005406A2 (pt) composição de vacina e respectivo uso
TWD169341S (zh) 用於空氣清淨機之片狀材料之部分
BR112014014504A2 (pt) uso de partícula
TR201901651T4 (tr) Yaşlanma izleyicileri.
TR201205852A2 (tr) Geliştirilmiş yeni kuru toz formülasyonu.
BR112013023575A2 (pt) “derivado de octaidrotienoquinolina, composição farmacêutica compreendendo o derivado, e uso destes”
TR201105367A2 (tr) Akış özellikleri geliştirilmiş bir kuru toz formülasyonu.
TR201100148A2 (tr) Stabil akarboz förmülasyonları.
IN2013CH01374A (tr)
BR112015004494A2 (pt) célula de fluxo de permeabilidade e sistema de condutância hidráulica
BR112015004348A2 (pt) célula de fluxo de permeabilidade e sistema de condutância hidráulica
TWD158777S (zh) 桌子(二)